ROWC yields 500000.00% · JNJ yields 2.14%● Live data
📍 ROWC pulled ahead of the other in Year 1
Combined, ROWC + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ROWC + JNJ for your $10,000?
The Rowe Companies, Inc. is a holding company, which through its subsidiaries manufactures and markets home furnishings in the United States. The company operates in two segments, Wholesale Home Furnishings and Retail Home Furnishings. The Wholesale Home Furnishings segment designs and manufactures upholstered furniture, including sofas, loveseats, benches, ottomans and chairs, occasional chairs, and sleep sofas covered with fabric, as well as finished leather accent pieces, such as chairs, benches, and ottomans. The Retail Home Furnishings segment offers upholstered furniture, leather furniture, case goods, dining sets, rugs, and home accessories through company-owned stores, catalog, and Internet. The Rowe Companies, Inc. was formerly known as Rowe Furniture Corporation and changed its name to The Rowe Companies, Inc. in March 1999. The Rowe Companies, Inc. was founded in 1946 and is based in McLean, Virginia. On September 18, 2006, The Rowe Companies, Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Eastern District of Virginia, Alexandria. The plan was later approved as Chapter 11 liquidation October 25, 2007.
Full ROWC Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.